Evaluating a Patient-Centered Tool to Help Medicare Beneficiaries Choose Prescription Drug Plans
CHOICE
3 other identifiers
interventional
1,185
0 countries
N/A
Brief Summary
The objective of this study is to determine whether providing Medicare beneficiaries with a web-based patient-centered decision tool to help them choose among prescription medication coverage plans improves outcomes for patients including a greater likelihood of changing a plan, better coverage for prescribed drugs, less decisional conflict when choosing plans, and greater satisfaction with the choice process relative to current practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2016
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 6, 2016
CompletedFirst Posted
Study publicly available on registry
September 9, 2016
CompletedStudy Start
First participant enrolled
September 10, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 20, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
January 20, 2017
CompletedResults Posted
Study results publicly available
July 23, 2019
CompletedJuly 23, 2019
July 1, 2019
4 months
September 6, 2016
January 31, 2018
July 18, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Count of Participants Whose 2017 Plan Differed From Their 2016 Plan
Indicator of whether the self-reported plan of the participant differed before and after open enrollment and the participant reported that s/he changed plans during open enrollment.
within 50 days of the end of the open enrollment period.
Decisional Conflict
Low literacy decisional conflict scale (Linder et al., 2011), edited slightly for context of health insurance rather than treatment choice. The scale has 4 subscales (uncertainty, informed, values clarity and support) with 2 to 3 questions per subscale. Respondents can indicate "yes", "no", or "unsure" for each item. An answer of "yes" receives 0, "unsure" receives 2 and "no" receives 4 points. The sum of the responses to each question within a subscale is normalized to a scale of 25. The subscales are then summed to a total score ranging from 0 to 100 where 0 represents the lowest level of decisional conflict and 100 represents the highest level of decisional conflict.
within 50 days of the end of the open enrollment period.
Satisfaction With the Choice Process
Response to the question of, "How satisfied are you with the process of choosing a plan?" with 4 potential responses: very satisfied, somewhat satisfied, somewhat dissatisfied and very dissatisfied. The count of participants who responded "very satisfied" is reported.
within 50 days of the end of the open enrollment period
Change in Estimated Prescription Drug Spending
Change in estimated prescription drug spending is the difference in estimated spending in US dollars, including both premiums and out-of-pocket spending on prescription drugs, between the participant's 2016 and 2017 plans based on their initial drug list.
within 50 days of the end of the open enrollment period
Study Arms (3)
Control
ACTIVE COMPARATORStudy subjects randomized to the control arm will receive information on how to download their prescription drug information from their electronic medical record and will be provided with a list of resources available in the community to help them choose a prescription drug plan.
Expert Recommendation
EXPERIMENTALParticipants randomized to the "Expert Recommendation" arm will receive access to a decision support tool that provides personalized expert scores for particular plans based on individual's likely annual out-of-pocket spending, including plan premiums and spending on prescription drugs, and the Medicare star ratings (a measure of customer satisfaction).
Individual Analysis
ACTIVE COMPARATORParticipants randomized to "Individual Analysis" arm will receive access to a decision support tool that provides individualized cost information for each plan but not the expert scores for particular plans.
Interventions
Decision support tool that provides personalized information on the financial implications of enrolling in different plans and expert recommendations of particular plans.
Decision support tool that provides personalized information on the financial implications of enrolling in different plans.
Study subjects randomized to the control arm will receive information on how to download their prescription drug information from their electronic medical record and provided with a list of resources available in the community to help them choose a prescription drug plan.
Eligibility Criteria
You may qualify if:
- The study population included Medicare beneficiaries who received care from the Palo Alto Medical Foundation, a large multi-specialty group in the San Francisco Bay Area ages 66-85, one per household enrolled in a Medicare Part D plan in 2016.
You may not qualify if:
- Enrolled in a Medicare Advantage Plan and/or MediCal
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Stanford Universitylead
- Palo Alto Medical Foundationcollaborator
- Patient-Centered Outcomes Research Institutecollaborator
Related Publications (1)
Linder SK, Swank PR, Vernon SW, Mullen PD, Morgan RO, Volk RJ. Validity of a low literacy version of the Decisional Conflict Scale. Patient Educ Couns. 2011 Dec;85(3):521-4. doi: 10.1016/j.pec.2010.12.012. Epub 2011 Feb 5.
PMID: 21300518BACKGROUND
Results Point of Contact
- Title
- Dr. M. Kate Bundorf
- Organization
- Stanford University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 6, 2016
First Posted
September 9, 2016
Study Start
September 10, 2016
Primary Completion
January 20, 2017
Study Completion
January 20, 2017
Last Updated
July 23, 2019
Results First Posted
July 23, 2019
Record last verified: 2019-07